Insurance Guide · Last verified: May 22, 2026

Does CVS Caremark Cover Wegovy? 2026 Coverage, PA & The “Covered But $1,300” Problem

Published: April 21, 2026 · Last updated: May 22, 2026

By The RX Index Editorial Team — a pricing intelligence and comparison resource for GLP-1 telehealth providers · Next scheduled review: August 22, 2026

CVS Caremark is a pharmacy benefit manager. Final coverage depends on your specific plan design.

CVS Caremark Wegovy verdict at a glance

Find your situation in the table to jump straight to the right answer.

First, the thing nobody explains: CVS Caremark is not your insurance

CVS Caremark is a Pharmacy Benefit Manager (PBM) — the middle layer between you, the pharmacy, and your insurance plan. Your employer or health insurer hires CVS Caremark to manage which drugs are covered, how much you pay, and what paperwork is required. The card in your wallet might say Aetna, Blue Cross, or any other carrier. If Caremark appears on it, Caremark sets the prescription rules.

This single point of confusion produces about half the frustration people have with CVS Caremark and Wegovy. Three different parties decide your coverage:

• CVS Caremark decides which drugs are on the template formulary, the prior authorization rules, and the pharmacy network.
• Your employer (or health plan) decides whether weight-loss medications are a covered benefit at all, whether to opt into the standard template formulary or customize it, and how to tier copays.
• The pharmacy decides nothing — it just processes the claim using the rules Caremark and your employer set.

Two people holding identical-looking CVS Caremark cards can get totally different answers because their employers made different benefit choices. That isn’t Caremark being inconsistent. That’s how the system is designed.

How to tell if CVS Caremark manages your pharmacy benefits

• Flip your insurance card over. Look for “Caremark,” “CVS Caremark,” or an RxBIN tied to CVS Caremark.
• Log into your HR benefits portal — there’s usually a line that reads “Pharmacy benefits administered by CVS Caremark.”
• If you’ve been filling prescriptions through caremark.com or the CVS Caremark app, you’re a Caremark member.

Does CVS Caremark cover Wegovy in 2026?

Yes. CVS Caremark prefers Wegovy 2.4 mg injection on its Standard Control, Advanced Control, and Value formularies effective July 1, 2025, and that preference continues through 2026. Your specific plan still has to opt into weight-loss-medication coverage, and you still have to clear prior authorization.

What changed in July 2025

For years, CVS Caremark covered multiple GLP-1 weight-loss drugs at the preferred tier — Saxenda, Wegovy, Qsymia, and Zepbound. That ended on July 1, 2025. CVS Caremark struck a preferred-pricing deal with Novo Nordisk that designated Wegovy as the preferred GLP-1 for obesity and removed Zepbound from the three standard template formularies. CVS Caremark’s stated reason: preferring one product drives competition and brings prices down.

If you had a Zepbound prior authorization in June 2025, many plans automatically transferred the PA dates to Wegovy when the change took effect. Your doctor still had to send a new Wegovy prescription, but the PA paperwork carried over on most plans. Confirm with your specific plan if you’re not sure. (See also: Does CVS Caremark cover Zepbound?)

What “preferred” usually means for your wallet

• Lower copay tier. Wegovy often lands at Tier 2 on plans that include weight-loss coverage.
• Smoother prior authorization. Plans usually apply Caremark’s standard PA criteria rather than custom criteria that may be stricter.
• No step therapy at the template level. You don’t have to fail a cheaper drug first to get Wegovy. Some employers do add step therapy on top — more on that in our step therapy guide.

Where Wegovy stands on each Caremark formulary

Source: CVS Caremark official GLP-1 formulary page; CVS spokesperson statement, October 2025. Verified May 22, 2026.

What “covered” actually means (the part that explains the $1,300 problem)

“Covered” is one word doing four different jobs. It can mean the drug is on the formulary, that prior authorization was approved, that the drug is preferred (better tier), or that a non-insurance discount is being shown. None of those guarantees a low price at the pharmacy counter. This single ambiguity causes most “covered but $1,300” surprises.

The four versions of “covered”

Why your PA can be approved and the pharmacy can still quote $1,300

Five common reasons:

1. You’re on a high-deductible health plan (HDHP) and the deductible isn’t met. Some CVS Caremark-administered HDHPs removed weight-loss medications from their preventive drug list, which means members pay toward the deductible first — even when the drug is covered. Ask whether your Wegovy claim is subject to the deductible.
2. You’re paying coinsurance, not a flat copay. A 30% coinsurance on Wegovy’s list price is hundreds of dollars per month — even though the drug is “covered.”
3. The pharmacy quoted you a discount-card price, not your plan’s price. Sometimes the lowest price shown at checkout is from a third-party discount tool rather than your actual benefit. Those discounts usually don’t apply toward your deductible.
4. Wrong product or wrong NDC. Wegovy comes in multiple forms (injection pen, oral tablets, Wegovy HD 7.2 mg). If your formulary covers one form and your prescription is for a different form, the price changes drastically.
5. The 2026 $200 employer copay tier. Some employers chose a 2026 Caremark cost-sharing option with patient copays up to $200 when they added weight-loss GLP-1 coverage. It’s plan-sponsor-specific, not automatic.

How to find out which version of “covered” applies to you

Call CVS Caremark member services. Ask these four questions in order:

1. “Is my Wegovy claim on benefit, or am I being shown a discount price?”
2. “Has my prior authorization been approved? If yes, what’s my exact copay or coinsurance?”
3. “Has my deductible been met for this plan year? Does this Wegovy payment apply to it?”
4. “Does the payment count toward my out-of-pocket maximum?”

If they can’t answer those clearly, ask for a supervisor or request the answers in writing. You’re allowed to request a written coverage determination.

How to check your exact CVS Caremark Wegovy coverage in 10 minutes

Log into caremark.com or the CVS Caremark app, search “Wegovy” in the drug cost and coverage tool, screenshot the result, then confirm with HR whether your employer includes weight-loss-medication coverage. If you’d rather not make the phone calls yourself, Ro’s free Insurance Coverage Checker reaches out to your plan on your behalf and emails you a personalized report.

CVS Caremark’s Wegovy prior authorization: exactly what they want

Prior authorization (PA) is the paperwork your doctor sends to CVS Caremark proving you medically qualify for Wegovy. The core requirements are a BMI of 30 or higher (or 27 with a qualifying weight-related condition), documentation of a structured weight-management program for at least six months, no contraindications, and confirmation that you’re not on another GLP-1. Most denials happen because of missing paperwork — not because the patient doesn’t qualify.

The actual CVS Caremark PA criteria for adults

Pulled directly from CVS Caremark’s published Wegovy PA criteria (policy 4774-C):

• Age: 18 or older
• BMI: ≥30 kg/m² (obesity), OR ≥27 kg/m² (overweight) with at least one weight-related comorbid condition
• Qualifying comorbidities: hypertension, type 2 diabetes mellitus, or dyslipidemia (high cholesterol) per FDA labeling
• Lifestyle program: documented participation in a comprehensive weight-management program (typically six months) including diet, increased physical activity, and behavioral counseling
• No contraindications: no personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• No concurrent GLP-1: you can’t be on another semaglutide product or another GLP-1 receptor agonist at the same time

What your doctor needs to send

Hand this checklist to your doctor before they submit. Missing documentation is the most common denial cause.

How long the PA takes

PA timing varies by plan, submission method, and whether the request is standard or urgent. NovoCare patient guidance says PA requests can take up to 10 business days. When the PA is submitted, ask your prescriber’s office for the case number and expected decision deadline.

Renewal (continuation) criteria

CVS Caremark’s public continuation criteria for adult long-term weight reduction require at least 3 months of therapy at a stable maintenance dose and documentation that the patient lost at least 5% of baseline body weight or maintained the initial 5% weight loss. If you haven’t hit 5%, the PA can be denied for non-response — and a peer-to-peer review with your prescriber is the right next step.

What you’ll actually pay for Wegovy with CVS Caremark

With CVS Caremark coverage plus the Wegovy Savings Card, eligible commercially insured patients can pay as low as $25/month. Without the savings card, your copay depends on tier — typically $25 to $150/month — or you might be on the 2026 $200 employer copay tier. If you’re on a high-deductible plan and haven’t met your deductible, you may pay close to the full list price (~$1,349/month) until the deductible is hit.

Your real cost paths compared

All prices verified May 22, 2026. Recheck before filling.

The Wegovy Savings Card explained

Novo Nordisk runs a manufacturer copay program through NovoCare. If you have commercial (non-government) insurance that covers Wegovy, the savings card brings your monthly copay as low as $25.

• $100 off a 1-month supply
• $200 off a 2-month supply
• $300 off a 3-month supply

Enroll at novocare.com/wegovy/savings-card.html. Important: not valid for Medicare, Medicaid, Tricare, VA, or any government insurance. Savings card payments usually don’t count toward your insurance deductible on an HDHP. See our full Wegovy Savings Card guide for enrollment steps.

Why some plans now show a $200 copay

In late 2025, CVS Caremark introduced a new cost-sharing option for employer plans that had been excluding weight-loss medications. The deal: employers and unions can opt to cover Wegovy and Zepbound for their members at a patient copay of up to $200 per 30-day supply. It’s plan-sponsor-specific, not automatic. It’s not as good as a $25 copay with the savings card. It’s a lot better than $1,300 cash.

If your CVS Caremark plan excludes weight-loss medications

About one in three CVS Caremark-managed employer plans excludes weight-loss medications entirely. If that’s you, no amount of better paperwork forces coverage. Your options:

Confirm the exclusion in writing first

Don’t take a verbal answer. Email HR or send a Caremark portal message asking for written confirmation that anti-obesity medications are excluded from your prescription benefit. You want this in writing for two reasons: appeals require documentation, and the Novo Nordisk Patient Assistance Program asks for proof that your plan doesn’t cover Wegovy.

Option 1 — The cardiovascular indication pathway

Wegovy is FDA-approved to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease who are overweight or obese. If you qualify medically, your doctor can submit the PA under this indication instead of weight management. Caremark’s published CV pathway criteria require: documented established cardiovascular disease (previous heart attack, previous stroke, symptomatic peripheral artery disease, or prior revascularization), baseline BMI ≥27, no type 2 diabetes (Caremark routes T2D + CVD patients to Ozempic, not Wegovy, for CV risk), and current guideline-directed management and therapy (GDMT). Some employer plans that exclude “weight-loss medications” still cover medications prescribed for cardiovascular conditions.

Option 2 — Advocate during open enrollment

Employers add GLP-1 coverage every year. Send a short, specific email to your benefits team: “I’d like to request that our prescription benefit add coverage for FDA-approved anti-obesity medications during the next open enrollment. CVS Caremark introduced a cost-sharing option in 2025 that allows employers to add this coverage at a $200/month patient copay, which is meaningfully cheaper than the prior $1,000+ list price. I’d appreciate the benefits committee considering it.” You’re handing them a specific, low-cost option to add.

Option 3 — Cash-pay through NovoCare Pharmacy

Novo Nordisk’s direct-to-consumer pharmacy sells FDA-approved Wegovy at:

• $349/month for the standard injection (0.25 mg through 2.4 mg) after the intro offer
• $199/month introductory for the first two fills of 0.25 mg or 0.5 mg through June 30, 2026
• $399/month for Wegovy HD 7.2 mg
• $149/month for Wegovy tablets at 1.5 mg and 4 mg (4 mg intro runs through August 31, 2026)

Compare all self-pay routes in our cheapest Wegovy without insurance guide.

Option 4 — Cash-pay through Ro with insurance-fight backup

Ro’s pricing for FDA-approved Wegovy matches NovoCare. The membership ($39 first month, then $149/month, or as low as $74/month with annual prepay) buys you provider visits, ongoing care, and an insurance concierge that will fight for coverage first — and fall back to cash-pay if your plan refuses. One platform, three possible outcomes: covered path, PA fight, or seamless cash-pay.

Option 5 — Sesame Care for branded GLP-1 self-pay

If you want a broader branded GLP-1 menu without the membership model, Sesame Care lists Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, and Saxenda. Costco members can access lower self-pay pricing on Wegovy injections through the Sesame–Costco partnership.

Option 6 — Novo Nordisk Patient Assistance Program

For uninsured patients who meet income limits, Novo Nordisk offers free Wegovy through their Patient Assistance Program. The application is at NovoCare.com. This is the right option for low-income patients without any insurance — it requires lack of any insurance coverage, not just lack of Wegovy coverage.

If your Wegovy prior authorization is denied

Read the denial reason first — it tells you which fix applies. Missing-documentation denials are often resubmitted quickly once the right paperwork is attached. True plan-exclusion denials require a different strategy. Many fixable denials are documentation problems matched to the wrong response. See our full Wegovy denial appeal guide for letter templates and peer-to-peer request scripts.

Denial triage table

Three appeal levels

1. Formulary exception / letter of medical necessity. Your doctor submits a written request explaining why Wegovy is medically necessary for you specifically, citing FDA labeling, prior treatment failures, and the specific clinical reason that addresses the denial.
2. Peer-to-peer review. Your prescribing doctor calls a CVS Caremark clinical reviewer directly to discuss the case. Peer-to-peer often resolves denials faster than written appeals because the conversation can clarify documentation gaps in real time. Your provider’s office requests this by calling the number on the denial letter.
3. External appeal. If internal appeals fail, you have the right to a formal external appeal through an Independent Review Organization (IRO). State insurance regulators publish overturn rates, and Wegovy appeals have been overturned in real cases when documentation supports medical necessity.

What to put in a Wegovy letter of medical necessity

Your doctor’s letter should include, in order:

1. Patient identification — name, DOB, member ID.
2. Current BMI and weight-related comorbidities with ICD-10 codes.
3. Documented prior weight-loss attempts — medications tried with dates and outcomes, supervised programs, surgeries.
4. Clinical justification for Wegovy specifically — FDA labeling, why semaglutide vs. alternatives, cardiovascular benefit if applicable, contraindications to alternative drugs.
5. Direct response to the denial reason — address the specific criterion that wasn’t met.
6. Statement of medical necessity signed by the prescribing physician.

Does CVS Caremark cover Wegovy for MASH?

Possibly — under a different pathway than weight loss. CVS Caremark’s public criteria include a Wegovy-injection-only pathway for noncirrhotic metabolic dysfunction–associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis (F2–F3) in adults, when prescribed by or in consultation with a gastroenterologist or hepatologist. This is separate from the weight-loss PA pathway and is only available for Wegovy injection, not Wegovy tablets.

If your plan excludes weight-loss medications but you have documented F2–F3 fibrosis from MASH, the MASH indication may be a separate path to coverage. Your gastroenterologist or hepatologist drives this submission, not your primary care doctor.

Does CVS Caremark cover Wegovy if I have type 2 diabetes?

You can still take Wegovy for weight loss if you have type 2 diabetes — it’s actually one of the qualifying comorbidities. But CVS Caremark’s published cardiovascular-risk pathway for Wegovy specifies the patient does NOT have type 2 diabetes; for T2D patients with established CVD, Caremark’s criteria route to Ozempic for CV risk reduction. Talk to your prescriber about which GLP-1 product fits both your diagnosis and your plan’s coverage rules.

Wegovy injection vs. tablets vs. HD — does CVS Caremark cover them the same?

Not necessarily. Each form has different FDA indications, and coverage rules can differ from plan to plan.

Wegovy injection (0.25 mg → 2.4 mg pens)

The most established coverage path. Preferred on the three CVS Caremark template formularies, eligible for the savings card, and the form most prior authorization templates default to. The injection has the broadest FDA indications: adult weight management, adult cardiovascular risk reduction, pediatric weight management (ages 12+), and noncirrhotic MASH with F2–F3 fibrosis.

Wegovy tablets (semaglutide oral)

FDA-approved December 22, 2025 and launched in early January 2026. Available through Ro and several other telehealth platforms. Wegovy tablets are FDA-approved for adult weight reduction/maintenance and adult cardiovascular risk reduction — not pediatric weight management or the MASH indication. CVS Caremark coverage of Wegovy tablets is rolling out plan-by-plan. Check the exact tablet dose in the Caremark drug cost tool.

Wegovy HD (semaglutide 7.2 mg injection)

FDA-approved March 19, 2026; launched in April. FDA says the 7.2 mg dose produces additional average weight reduction compared with previously approved doses. The Wegovy Savings Card covers Wegovy HD under the same program. NovoCare cash-pay pricing is $399/month.

Does the Medicare GLP-1 Bridge cover Wegovy through CVS Caremark?

Yes, beginning July 1, 2026. CMS says eligible Medicare Part D beneficiaries may access Wegovy injection and Wegovy tablets for weight reduction and maintenance through the Medicare GLP-1 Bridge at $50 for a monthly supply. This is separate from standard Medicare Part D weight-loss rules and separate from Wegovy’s cardiovascular-risk indication coverage on Part D.

Standard Medicare Part D rules

Federal law prohibits Medicare Part D from covering drugs prescribed for weight loss alone. That has been true since Part D launched. However, Medicare Part D plans (including plans administered through CVS Caremark) can cover Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease and BMI ≥27, with prior authorization typically required.

If you’re on Medicare Part D through CVS Caremark and you’ve been told Wegovy isn’t covered for weight loss, ask your plan specifically about Bridge eligibility starting July 1, 2026. See our full guide: Does Medicare cover Wegovy?

Medicaid, TRICARE, and FEHB through CVS Caremark

Medicaid through CVS Caremark

Medicaid is state-administered. Some state Medicaid programs cover Wegovy for weight management; many do not. California Medi-Cal removed Wegovy from its weight-loss coverage effective January 1, 2026 — Wegovy is now only covered in California for noncirrhotic MASH or cardiovascular disease indications. See our Medicaid Wegovy coverage guide for state-by-state details.

TRICARE

TRICARE covers Wegovy, Saxenda, and Zepbound for weight management for specified beneficiary groups — including TRICARE Prime, Select, US Family Health Plan, Young Adult, Reserve Select, Retired Reserve, and Continued Health Care Benefit Program members — when clinical criteria, network-prescriber requirements, and prior authorization are met. TRICARE does not cover weight-loss medications for TRICARE For Life beneficiaries and certain other groups. Confirm your specific plan with your TRICARE pharmacy contractor. See also: Does TRICARE cover Wegovy?

Note: The Wegovy Savings Card is not valid for any government insurance.

Federal Employees Health Benefits Program (FEHB)

FEHB is a marketplace of plans from different carriers, some of which use CVS Caremark and some of which don’t. Coverage of Wegovy varies dramatically by carrier and plan year. The 2026 FEHB plan brochures list which carriers cover anti-obesity medications. If you’re a federal employee on an FEHB plan using CVS Caremark, Ro’s insurance concierge can handle the coverage paperwork.

Common CVS Caremark Wegovy scenarios

These aren’t testimonials — they’re patterns mapped from public coverage questions and the CVS Caremark policies above.

Wegovy safety basics

What we actually verified for this page

What we can’t verify for you specifically

These depend on your exact situation and you’ll need to confirm them: your exact CVS Caremark plan’s coverage of Wegovy, whether your employer customized the formulary or excluded weight-loss meds, your specific copay or coinsurance amount, your current deductible status, your pharmacy’s live inventory, your final prior authorization outcome, your state’s specific Medicaid GLP-1 rules, and any unannounced plan amendments. For all of these, use the CVS Caremark drug cost tool, your HR benefits team, or Ro’s free Coverage Checker.

Frequently asked questions

Your action plan

If you took nothing else from this page, do these five things in this order:

1. Sign into caremark.com or the CVS Caremark app. Search “Wegovy” in the drug cost and coverage tool. Screenshot the result.
2. Email HR. Ask whether anti-obesity medications are a covered benefit and whether your plan uses a standard or custom CVS Caremark formulary.
3. Send your doctor the PA checklist in the prior authorization section above. The right paperwork the first time is the difference between a 5-day approval and a 5-week denial spiral.
4. Activate the Wegovy Savings Card at novocare.com/wegovy/savings-card.html if you have commercial insurance. This is the single biggest lever for getting your copay down to $25.
5. If your plan excludes weight-loss meds, or you want help with the paperwork, use Ro’s free GLP-1 Insurance Coverage Checker to confirm in writing, then decide whether Ro’s insurance concierge or a cash-pay path makes more sense for you.